Evidence map›Paper›PMID 33137440›Full record

SynthesisJournal of the American Academy of Dermatology2021

Incidence of dermatologic adverse events in patients with cancer treated with concurrent immune checkpoint inhibitors and radiation therapy: A systematic review and meta-analysis.

Bernice Y Yan, Gloria Wasilewski, Mario E Lacouture, Christopher A Barker

Open access · greenAbstract readLetterMeta-AnalysisSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Journal of the American Academy of Dermatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Bernice Y YanDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Dermatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, New York.
Gloria WasilewskiDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Mario E LacoutureDermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Christopher A BarkerDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: barkerc@mskcc.org.
Memorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
SEAL (Stopping Atopic dermatitis and ALlergy) Study: Prevent allergy by enhancing the skin barrierU01AI147462 · NIAID · STANFORD UNIVERSITY · PI Mary Johnson, GIDEON LACK · 2020 to 2026
$14.0M
Identification of pathways to mitigate Immune-Related Adverse Events with Cancer Immunotherapy U01AR077511 · NIAMS · NATIONAL JEWISH HEALTH · PI KERN, JEFFREY A, LACOUTURE, MARIO · 2020 to 2024
$3.1M
NCI NIH HHS P30 CA008748NIAID NIH HHS U01 AI147462NIAMS NIH HHS U01 AR077511
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ChemoradiotherapyClinical Trials as TopicDrug EruptionsHumansImmune Checkpoint InhibitorsIncidenceNeoplasmsRadiodermatitisImmune Checkpoint Inhibitors

Identifiers

PMID33137440
PMCPMC7897249
OpenAlexW3096318749

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.